|
A placebo controlled treatment trial of sertraline and interpersonal psychotherapy for postpartum depression.
|
O'Hara MW., Pearlstein T., Stuart S., Long JD., Mills JA., Zlotnick C. |
2019 |
|
The Relationship Between Pregnancy Exposure to Antidepressant and Atypical Antipsychotic Medications and Placental Weight and Birth Weight Ratio: A Retrospective Cohort Study.
|
Frayne J., Nguyen T., Hauck Y., Liira H., Keelan JA. |
2018 |
|
Neonatal outcomes in pregnant women with untreated and treated panic disorder.
|
Uguz F., Yuksel G., Onur OS., Karsidag C., Gezginc K., Arpaci N. |
2018 |
|
Alterations in Resting-State Networks Following In Utero Selective Serotonin Reuptake Inhibitor Exposure in the Neonatal Brain.
|
Rotem-Kohavi N., Williams LJ., Virji-Babul N., Bjornson BH., Brain U., Werker JF., Grunau RE., Miller SP., Oberlander TF. |
2019 |
|
Brexanolone injection in post-partum depression: two multicentre, double-blind, randomised, placebo-controlled, phase 3 trials.
|
Meltzer-Brody S., Colquhoun H., Riesenberg R., Epperson CN., Deligiannidis KM., Rubinow DR., Li H., Sankoh AJ., Clemson C., Schacterle A., Jonas J., Kanes S. |
2018 |
|
The use of antidepressant drugs in pregnant women with epilepsy: A study from the Australian Pregnancy Register.
|
Sivathamboo N., Hitchcock A., Graham J., Sivathamboo S., Chen Z., O'Brien TJ., Vajda FJE. |
2018 |
|
Risk of Major Malformations in Infants Following First-Trimester Exposure to Quetiapine.
|
Cohen LS., Góez-Mogollón L., Sosinsky AZ., Savella GM., Viguera AC., Chitayat D., Hernández-Díaz S., Freeman MP. |
2018 |
|
Reproductive Safety of Second-Generation Antipsychotics: Current Data From the Massachusetts General Hospital National Pregnancy Registry for Atypical Antipsychotics.
|
Cohen LS., Viguera AC., McInerney KA., Freeman MP., Sosinsky AZ., Moustafa D., Marfurt SP., Kwiatkowski MA., Murphy SK., Farrell AM., Chitayat D., Hernández-Díaz S. |
2016 |
|
Major depressive disorder during pregnancy: Psychiatric medications have minimal effects on the fetus and infant yet development is compromised.
|
Gustafsson HC., Goodman SH., Feng T., Choi J., Lee S., Newport DJ., Knight B., Pingeton B., Stowe ZN., Monk C. |
2018 |
|
Comparison of two different treatments in depressed pregnant women: fetal growth characteristics and neonatal outcomes.
|
Giardinelli L., Lelli L., Ugolini V., Lazzeretti L., Burian I., Lino G., Lunardi C., Castellini G., Ricca V. |
2018 |
|
Obstetrical and neonatal outcomes after benzodiazepine exposure during pregnancy: Results from a prospective registry of women with psychiatric disorders.
|
Freeman MP., Góez-Mogollón L., McInerney KA., Davies AC., Church TR., Sosinsky AZ., Noe OB., Viguera AC., Cohen LS. |
-- Not Found -- |
|
Aripiprazole and pregnancy: A retrospective, multicentre study.
|
Galbally M., Frayne J., Watson SJ., Snellen M. |
2018 |
|
Antidepressants and recurrence of depression in the postpartum period.
|
Pope CJ., Sharma V., Sommerdyk C., Mazmanian D. |
2018 |
|
Self-reported perinatal depressive symptoms and postnatal symptom severity after treatment with antidepressants in pregnancy: a cross-sectional study across 12 European countries using the Edinburgh Postnatal Depression Scale.
|
Lupattelli A., Twigg MJ., Zagorodnikova K., Moretti ME., Drozd M., Panchaud A., Rieutord A., Juraski RG., Odalovic M., Kennedy D., Rudolf G., Juch H., Nordeng H. |
2018 |
|
Effect of Time-Dependent Selective Serotonin Reuptake Inhibitor Antidepressants During Pregnancy on Behavioral, Emotional, and Social Development in Preschool-Aged Children.
|
Lupattelli A., Wood M., Ystrom E., Skurtveit S., Handal M., Nordeng H. |
2018 |
|
Maternal mood disorders and lithium exposure in utero were not associated with poor cognitive development during childhood.
|
Forsberg L., Adler M., Römer Ek I., Ljungdahl M., Navér L., Gustafsson LL., Berglund G., Chotigasatien A., Hammar U., Böhm B., Wide K. |
2018 |
|
Gestational Weight Gain and Pre-pregnancy Body Mass Index Associated With Second-Generation Antipsychotic Drug Use During Pregnancy.
|
Freeman MP., Sosinsky AZ., Goez-Mogollon L., Savella GM., Moustafa D., Viguera AC., Cohen LS. |
-- Not Found -- |
|
Antidepressant Use in Late Gestation and Breastfeeding Rates at Discharge from Hospital.
|
Leggett C., Costi L., Morrison JL., Clifton VL., Grzeskowiak LE. |
2017 |
|
Antidepressant use during pregnancy and psychiatric disorders in offspring: Danish nationwide register based cohort study.
|
Liu X., Agerbo E., Ingstrup KG., Musliner K., Meltzer-Brody S., Bergink V., Munk-Olsen T. |
2017 |
|
Risk of preeclampsia after gestational exposure to selective serotonin reuptake inhibitors and other antidepressants: A study from The Norwegian Mother and Child Cohort Study.
|
Lupattelli A., Wood M., Lapane K., Spigset O., Nordeng H. |
2017 |
|
Use of atypical antipsychotics in pregnancy and maternal gestational diabetes.
|
Panchaud A., Hernandez-Diaz S., Freeman MP., Viguera AC., MacDonald SC., Sosinsky AZ., Cohen LS. |
2017 |
|
Antidepressants during pregnancy and autism in offspring: population based cohort study.
|
Rai D., Lee BK., Dalman C., Newschaffer C., Lewis G., Magnusson C. |
2017 |
|
Association of Antidepressant Medication Use During Pregnancy With Intellectual Disability in Offspring.
|
Viktorin A., Uher R., Kolevzon A., Reichenberg A., Levine SZ., Sandin S. |
2017 |
|
Mood symptoms in pregnant and postpartum women with bipolar disorder: a naturalistic study.
|
Driscoll KE., Sit DKY., Moses-Kolko EL., Pinheiro E., Yang A., Ciolino JD., Eng HF., Luther JF., Clark CT., Wisniewski SR., Wisner KL. |
2017 |
|
Antidepressant Use in Pregnancy and the Risk of Attention Deficit with or without Hyperactivity Disorder in Children.
|
Boukhris T., Sheehy O., Bérard A. |
2017 |
|
Brexanolone (SAGE-547 injection) in post-partum depression: a randomised controlled trial.
|
Kanes S., Colquhoun H., Gunduz-Bruce H., Raines S., Arnold R., Schacterle A., Doherty J., Epperson CN., Deligiannidis KM., Riesenberg R., Hoffmann E., Rubinow D., Jonas J., Paul S., Meltzer-Brody S. |
2017 |
|
Use of antidepressant medication in pregnancy and adverse neonatal outcomes: A population-based investigation.
|
Cantarutti A., Merlino L., Giaquinto C., Corrao G. |
2017 |
|
Lithium Use in Pregnancy and the Risk of Cardiac Malformations.
|
Patorno E., Huybrechts KF., Bateman BT., Cohen JM., Desai RJ., Mogun H., Cohen LS., Hernandez-Diaz S. |
2017 |
|
Neonatal Discontinuation Syndrome in Serotonergic Antidepressant-Exposed Neonates.
|
Yang A., Ciolino JD., Pinheiro E., Rasmussen-Torvik LJ., Sit DKY., Wisner KL. |
2017 |
|
Prenatal antidepressant use and risk of attention-deficit/hyperactivity disorder in offspring: population based cohort study.
|
Man KKC., Chan EW., Ip P., Coghill D., Simonoff E., Chan PKL., Lau WCY., Schuemie MJ., Sturkenboom MCJM., Wong ICK. |
2017 |
|
Autism risk following antidepressant medication during pregnancy.
|
Viktorin A., Uher R., Reichenberg A., Levine SZ., Sandin S. |
2017 |
|
Risk of postpartum episodes in women with bipolar disorder after lamotrigine or lithium use during pregnancy: A population-based cohort study.
|
Wesseloo R., Liu X., Clark CT., Kushner SA., Munk-Olsen T., Bergink V. |
2017 |
|
Pregnancy and postpartum antidepressant use moderates the effects of sleep on depression.
|
Stone KC., Salisbury AL., Miller-Loncar CL., Mattera JA., Battle CL., Johnsen DM., O'Grady KE. |
2017 |
|
The effects of gestational use of antidepressants and antipsychotics on neonatal outcomes for women with severe mental illness.
|
Frayne J., Nguyen T., Bennett K., Allen S., Hauck Y., Liira H. |
2017 |
|
Antidepressant use during pregnancy and the risk of major congenital malformations in a cohort of depressed pregnant women: an updated analysis of the Quebec Pregnancy Cohort.
|
Bérard A., Zhao JP., Sheehy O. |
2017 |
|
Is the Risk of Preterm Birth and Low Birth Weight Affected by the Use of Antidepressant Agents during Pregnancy? A Population-Based Investigation.
|
Cantarutti A., Merlino L., Monzani E., Giaquinto C., Corrao G. |
2016 |
|
Association of Selective Serotonin Reuptake Inhibitor Exposure During Pregnancy With Speech, Scholastic, and Motor Disorders in Offspring.
|
Brown AS., Gyllenberg D., Malm H., McKeague IW., Hinkka-Yli-Salomäki S., Artama M., Gissler M., Cheslack-Postava K., Weissman MM., Gingrich JA., Sourander A. |
2016 |
|
Prenatal exposure to antidepressants and risk of epilepsy in childhood.
|
Mao Y., Pedersen LH., Christensen J., Vestergaard M., Zhou W., Olsen J., Sun Y. |
2016 |
|
Prenatal antidepressant exposure and child behavioural outcomes at 7 years of age: a study within the Danish National Birth Cohort.
|
Grzeskowiak LE., Morrison JL., Henriksen TB., Bech BH., Obel C., Olsen J., Pedersen LH. |
2016 |
|
Prenatal exposure to selective serotonin reuptake inhibitors and childhood overweight at 7 years of age.
|
Grzeskowiak LE., Gilbert AL., Sørensen TI., Olsen J., Sørensen HT., Pedersen LH., Morrison JL. |
2013 |
|
Prenatal exposure to selective serotonin reuptake inhibitors and non-verbal cognitive functioning in childhood.
|
El Marroun H., White TJ., Fernandez G., Jaddoe VW., Verhulst FC., Stricker BH., Tiemeier H. |
2017 |
|
Selective serotonin reuptake inhibitors and autism: additional data on the Quebec Pregnancy/Birth Cohort.
|
Bérard A., Boukhris T., Sheehy O. |
2016 |
|
Risk of gestational hypertension and preeclampsia in women who discontinued or continued antidepressant medication use during pregnancy.
|
De Ocampo MPG., Araneta MRG., Macera CA., Alcaraz JE., Moore TR., Chambers CD. |
2016 |
|
Gestational Exposure to Selective Serotonin Reuptake Inhibitors and Offspring Psychiatric Disorders: A National Register-Based Study.
|
Malm H., Brown AS., Gissler M., Gyllenberg D., Hinkka-Yli-Salomäki S., McKeague IW., Weissman M., Wickramaratne P., Artama M., Gingrich JA., Sourander A. |
2016 |
|
Risk of Miscarriage in Women Receiving Antidepressants in Early Pregnancy, Correcting for Induced Abortions.
|
Almeida ND., Basso O., Abrahamowicz M., Gagnon R., Tamblyn R. |
2016 |
|
Preschool outcomes following prenatal serotonin reuptake inhibitor exposure: differences in language and behavior, but not cognitive function.
|
Johnson KC., Smith AK., Stowe ZN., Newport DJ., Brennan PA. |
2016 |
|
Behavior and inhibitory control in children with prenatal exposure to antidepressants and medically untreated depression.
|
Hermansen TK., Røysamb E., Augusti EM., Melinder A. |
2016 |
|
Depression, anxiety, and antidepressant treatment in women: association with in vitro fertilization outcome.
|
Cesta CE., Viktorin A., Olsson H., Johansson V., Sjölander A., Bergh C., Skalkidou A., Nygren KG., Cnattingius S., Iliadou AN. |
2016 |
|
The effect of antidepressants on fertility.
|
Casilla-Lennon MM., Meltzer-Brody S., Steiner AZ. |
2016 |
|
Antidepressant Use During Pregnancy and the Risk of Autism Spectrum Disorder in Children.
|
Boukhris T., Sheehy O., Mottron L., Bérard A. |
2016 |
|
The Roles of Maternal Depression, Serotonin Reuptake Inhibitor Treatment, and Concomitant Benzodiazepine Use on Infant Neurobehavioral Functioning Over the First Postnatal Month.
|
Salisbury AL., O'Grady KE., Battle CL., Wisner KL., Anderson GM., Stroud LR., Miller-Loncar CL., Young ME., Lester BM. |
2016 |
|
Pregnancy Complications Following Prenatal Exposure to SSRIs or Maternal Psychiatric Disorders: Results From Population-Based National Register Data.
|
Malm H., Sourander A., Gissler M., Gyllenberg D., Hinkka-Yli-Salomäki S., McKeague IW., Artama M., Brown AS. |
2015 |
|
Methodological considerations in assessing the effectiveness of antidepressant medication continuation during pregnancy using administrative data.
|
Swanson SA., Hernandez-Diaz S., Palmsten K., Mogun H., Olfson M., Huybrechts KF. |
2015 |
|
Antidepressant use late in pregnancy and risk of persistent pulmonary hypertension of the newborn.
|
Huybrechts KF., Bateman BT., Palmsten K., Desai RJ., Patorno E., Gopalakrishnan C., Levin R., Mogun H., Hernandez-Diaz S. |
2015 |
|
Pregnancy outcome following maternal exposure to mirtazapine: a multicenter, prospective study.
|
Winterfeld U., Klinger G., Panchaud A., Stephens S., Arnon J., Malm H., Te Winkel B., Clementi M., Pistelli A., Maňáková E., Eleftheriou G., Merlob P., Kaplan YC., Buclin T., Rothuizen LE. |
2015 |
|
Antidepressant medication use, depression, and the risk of preeclampsia.
|
Avalos LA., Chen H., Li DK. |
2015 |
|
Antidepressant use during pregnancy and asthma in the offspring.
|
Liu X., Olsen J., Pedersen LH., Agerbo E., Yuan W., Li J. |
2015 |
|
No association between prenatal exposure to psychotropics and intelligence at age five.
|
Eriksen HL., Kesmodel US., Pedersen LH., Mortensen EL. |
2015 |
|
Sertraline use during pregnancy and the risk of major malformations.
|
Bérard A., Zhao JP., Sheehy O. |
2015 |
|
Treatment of postnatal depression with cognitive behavioural therapy, sertraline and combination therapy: a randomised controlled trial.
|
Milgrom J., Gemmill AW., Ericksen J., Burrows G., Buist A., Reece J. |
2015 |
|
Maternal use of selective serotonin reuptake inhibitors and risk of miscarriage - assessing potential biases.
|
Johansen RL., Mortensen LH., Andersen AM., Hansen AV., Strandberg-Larsen K. |
2015 |
|
Impact of prenatal exposure to serotonin reuptake inhibitors or maternal major depressive disorder on infant developmental outcomes.
|
Santucci AK., Singer LT., Wisniewski SR., Luther JF., Eng HF., Dills JL., Sit DK., Hanusa BH., Wisner KL. |
2014 |
|
First trimester exposure to anxiolytic and hypnotic drugs and the risks of major congenital anomalies: a United Kingdom population-based cohort study.
|
Ban L., West J., Gibson JE., Fiaschi L., Sokal R., Doyle P., Hubbard R., Smeeth L., Tata LJ. |
2014 |
|
Antidepressant use in pregnancy and the risk of cardiac defects.
|
Huybrechts KF., Palmsten K., Avorn J., Cohen LS., Holmes LB., Franklin JM., Mogun H., Levin R., Kowal M., Setoguchi S., Hernández-Díaz S. |
2014 |
|
Pregnancy outcome following in utero exposure to lithium: a prospective, comparative, observational study.
|
Diav-Citrin O., Shechtman S., Tahover E., Finkel-Pekarsky V., Arnon J., Kennedy D., Erebara A., Einarson A., Ornoy A. |
2014 |
|
Maternal depression, antidepressant prescriptions, and congenital anomaly risk in offspring: a population-based cohort study.
|
Ban L., Gibson JE., West J., Fiaschi L., Sokal R., Smeeth L., Doyle P., Hubbard RB., Tata LJ. |
2014 |
|
Birth weight and preterm birth in babies of pregnant women with major depression in relation to treatment with antidepressants.
|
Şahingöz M., Yuksel G., Karsidag C., Uguz F., Sonmez EO., Annagur BB., Annagur A. |
2014 |
|
Effects of maternal psychotropic drug dosage on birth outcomes.
|
Michielsen LA., van der Heijden FM., Janssen PK., Kuijpers HJ. |
2014 |
|
Perinatal outcomes of pregnancies complicated by maternal depression with or without selective serotonin reuptake inhibitor therapy.
|
Engelstad HJ., Roghair RD., Calarge CA., Colaizy TT., Stuart S., Haskell SE. |
2014 |
|
Use of selective serotonin reuptake inhibitors during pregnancy and risk of autism.
|
Hviid A., Melbye M., Pasternak B. |
2013 |
|
Antidepressant exposure in pregnancy and risk of autism spectrum disorders.
|
Sørensen MJ., Grønborg TK., Christensen J., Parner ET., Vestergaard M., Schendel D., Pedersen LH. |
2013 |
|
A randomized, placebo-controlled, double-blind trial of sertraline for postpartum depression.
|
Hantsoo L., Ward-O'Brien D., Czarkowski KA., Gueorguieva R., Price LH., Epperson CN. |
2014 |
|
Risk of vaginal bleeding and postpartum hemorrhage after use of antidepressants in pregnancy: a study from the Norwegian Mother and Child Cohort Study.
|
Lupattelli A., Spigset O., Koren G., Nordeng H. |
2014 |
|
Use of antidepressants near delivery and risk of postpartum hemorrhage: cohort study of low income women in the United States.
|
Palmsten K., Hernández-Díaz S., Huybrechts KF., Williams PL., Michels KB., Achtyes ED., Mogun H., Setoguchi S. |
2013 |
|
Antidepressant use and risk for preeclampsia.
|
Palmsten K., Huybrechts KF., Michels KB., Williams PL., Mogun H., Setoguchi S., Hernández-Díaz S. |
2013 |
|
Does fetal exposure to SSRIs or maternal depression impact infant growth?
|
Wisner KL., Bogen DL., Sit D., McShea M., Hughes C., Rizzo D., Confer A., Luther J., Eng H., Wisniewski SW. |
2013 |
|
Neurodevelopment of children following prenatal exposure to venlafaxine, selective serotonin reuptake inhibitors, or untreated maternal depression.
|
Nulman I., Koren G., Rovet J., Barrera M., Pulver A., Streiner D., Feldman B. |
2012 |
|
Prenatal antidepressant exposure and behavioral problems in early childhood--a cohort study.
|
Pedersen LH., Henriksen TB., Bech BH., Licht RW., Kjaer D., Olsen J. |
2013 |
|
Prenatal exposure to antidepressants and depressed maternal mood alter trajectory of infant speech perception.
|
Weikum WM., Oberlander TF., Hensch TK., Werker JF. |
2012 |
|
Live and non-live pregnancy outcomes among women with depression and anxiety: a population-based study.
|
Ban L., Tata LJ., West J., Fiaschi L., Gibson JE. |
2012 |
|
Neonatal outcomes after late-gestation exposure to selective serotonin reuptake inhibitors.
|
Grzeskowiak LE., Gilbert AL., Morrison JL. |
2012 |
|
Maternal antidepressant use and adverse outcomes: a cohort study of 228,876 pregnancies.
|
Hayes RM., Wu P., Shelton RC., Cooper WO., Dupont WD., Mitchel E., Hartert TV. |
2012 |
|
Prenatal antipsychotic exposure and neuromotor performance during infancy.
|
Johnson KC., LaPrairie JL., Brennan PA., Stowe ZN., Newport DJ. |
2012 |
|
Elevated risk of preeclampsia in pregnant women with depression: depression or antidepressants?
|
Palmsten K., Setoguchi S., Margulis AV., Patrick AR., Hernández-Díaz S. |
2012 |
|
Affect Expression and Self-Regulation Capacities of Infants Exposed in utero to Psychotropics.
|
Reebye PN., Ng TW., Misri S., Stikarovska I. |
2012 |
|
The effect of sertraline add-on to brief dynamic psychotherapy for the treatment of postpartum depression: a randomized, double-blind, placebo-controlled study.
|
Bloch M., Meiboom H., Lorberblatt M., Bluvstein I., Aharonov I., Schreiber S. |
2012 |
|
Pregnancy outcomes following use of escitalopram: a prospective comparative cohort study.
|
Klieger-Grossmann C., Weitzner B., Panchaud A., Pistelli A., Einarson T., Koren G., Einarson A. |
2012 |
|
Newborn neurobehavioral patterns are differentially related to prenatal maternal major depressive disorder and serotonin reuptake inhibitor treatment.
|
Salisbury AL., Wisner KL., Pearlstein T., Battle CL., Stroud L., Lester BM. |
2011 |
|
A prospective, naturalistic, blinded study of early neurobehavioral outcomes for infants following prenatal antidepressant exposure.
|
Suri R., Hellemann G., Stowe ZN., Cohen LS., Aquino A., Altshuler LL. |
2011 |
|
Association between antidepressant use during pregnancy and infants born small for gestational age.
|
Ramos É., St-André M., Bérard A. |
2010 |
|
Use of antidepressants during pregnancy and the risk of spontaneous abortion.
|
Nakhai-Pour HR., Broy P., Bérard A. |
2010 |
|
Antidepressant use during pregnancy and the risk of preterm delivery and fetal growth restriction.
|
Toh S., Mitchell AA., Louik C., Werler MM., Chambers CD., Hernández-Díaz S. |
2009 |
|
Maternal schizophrenia and pregnancy outcome: does the use of antipsychotics make a difference?
|
Lin HC., Chen IJ., Chen YH., Lee HC., Wu FJ. |
2010 |
|
Selective serotonin reuptake inhibitors in pregnancy and congenital malformations: population based cohort study.
|
Pedersen LH., Henriksen TB., Vestergaard M., Olsen J., Bech BH. |
2009 |
|
Placental transfer of SSRI and SNRI antidepressants and effects on the neonate.
|
Rampono J., Simmer K., Ilett KF., Hackett LP., Doherty DA., Elliot R., Kok CH., Coenen A., Forman T. |
2009 |
|
Major depression and antidepressant treatment: impact on pregnancy and neonatal outcomes.
|
Wisner KL., Sit DK., Hanusa BH., Moses-Kolko EL., Bogen DL., Hunker DF., Perel JM., Jones-Ivy S., Bodnar LM., Singer LT. |
2009 |
|
Sexual function in postpartum women treated for depression: results from a randomized trial of nortriptyline versus sertraline.
|
Lanza di Scalea T., Hanusa BH., Wisner KL. |
2009 |
|
Postpartum depression: a randomized trial of sertraline versus nortriptyline.
|
Wisner KL., Hanusa BH., Perel JM., Peindl KS., Piontek CM., Sit DK., Findling RL., Moses-Kolko EL. |
2006 |
|
Serotonin reuptake inhibitor use in pregnancy and the neonatal behavioral syndrome.
|
Jordan AE., Jackson GL., Deardorff D., Shivakumar G., McIntire DD., Dashe JS. |
2008 |
|
Birth weight of infants after maternal exposure to typical and atypical antipsychotics: prospective comparison study.
|
Newham JJ., Thomas SH., MacRitchie K., McElhatton PR., McAllister-Williams RH. |
2008 |
|
Lamotrigine in bipolar disorder: efficacy during pregnancy.
|
Newport DJ., Stowe ZN., Viguera AC., Calamaras MR., Juric S., Knight B., Pennell PB., Baldessarini RJ. |
2008 |
|
Pharmacologic treatment of postpartum women with new-onset major depressive disorder: a randomized controlled trial with paroxetine.
|
Yonkers KA., Lin H., Howell HB., Heath AC., Cohen LS. |
2008 |
|
Risk of recurrence in women with bipolar disorder during pregnancy: prospective study of mood stabilizer discontinuation.
|
Viguera AC., Whitfield T., Baldessarini RJ., Newport DJ., Stowe Z., Reminick A., Zurick A., Cohen LS. |
2007 |
|
Birth outcomes following prenatal exposure to antidepressants.
|
Pearson KH., Nonacs RM., Viguera AC., Heller VL., Petrillo LF., Brandes M., Hennen J., Cohen LS. |
2007 |
|
Risks of congenital malformations and perinatal events among infants exposed to antidepressant medications during pregnancy.
|
Davis RL., Rubanowice D., McPhillips H., Raebel MA., Andrade SE., Smith D., Yood MU., Platt R. |
2007 |
|
Atypical antipsychotic administration during late pregnancy: placental passage and obstetrical outcomes.
|
Newport DJ., Calamaras MR., DeVane CL., Donovan J., Beach AJ., Winn S., Knight BT., Gibson BB., Viguera AC., Owens MJ., Nemeroff CB., Stowe ZN. |
2007 |
|
Effects of antenatal depression and antidepressant treatment on gestational age at birth and risk of preterm birth.
|
Suri R., Altshuler L., Hellemann G., Burt VK., Aquino A., Mintz J. |
2007 |
|
First trimester exposure to paroxetine and risk of cardiac malformations in infants: the importance of dosage.
|
Bérard A., Ramos E., Rey E., Blais L., St-André M., Oraichi D. |
2007 |
|
Exposure to mirtazapine during pregnancy: a prospective, comparative study of birth outcomes.
|
Djulus J., Koren G., Einarson TR., Wilton L., Shakir S., Diav-Citrin O., Kennedy D., Voyer Lavigne S., De Santis M., Einarson A. |
2006 |
|
Patient choice of treatment for postpartum depression: a pilot study.
|
Pearlstein TB., Zlotnick C., Battle CL., Stuart S., O'Hara MW., Price AB., Grause MA., Howard M. |
2006 |
|
Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data.
|
Oberlander TF., Warburton W., Misri S., Aghajanian J., Hertzman C. |
2006 |
|
Olanzapine in the prevention of postpartum psychosis and mood episodes in bipolar disorder.
|
Sharma V., Smith A., Mazmanian D. |
2006 |
|
Internalizing behaviors in 4-year-old children exposed in utero to psychotropic medications.
|
Misri S., Reebye P., Kendrick K., Carter D., Ryan D., Grunau RE., Oberlander TF. |
2006 |
|
Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment.
|
Cohen LS., Altshuler LL., Harlow BL., Nonacs R., Newport DJ., Viguera AC., Suri R., Burt VK., Hendrick V., Reminick AM., Loughead A., Vitonis AF., Stowe ZN. |
2006 |
|
Citalopram use in pregnancy: prospective comparative evaluation of pregnancy and fetal outcome.
|
Sivojelezova A., Shuhaiber S., Sarkissian L., Einarson A., Koren G. |
2005 |
|
Pregnancy outcome of women exposed to bupropion during pregnancy: a prospective comparative study.
|
Chun-Fai-Chan B., Koren G., Fayez I., Kalra S., Voyer-Lavigne S., Boshier A., Shakir S., Einarson A. |
2005 |
|
Prevention of postpartum episodes in women with bipolar disorder.
|
Wisner KL., Hanusa BH., Peindl KS., Perel JM. |
2004 |
|
The impact of depression and fluoxetine treatment on obstetrical outcome.
|
Suri R., Altshuler L., Hendrick V., Rasgon N., Lee E., Mintz J. |
2004 |
|
Neonate characteristics after maternal use of antidepressants in late pregnancy.
|
Källén B. |
2004 |
|
Pharmacologic factors associated with transient neonatal symptoms following prenatal psychotropic medication exposure.
|
Oberlander TF., Misri S., Fitzgerald CE., Kostaras X., Rurak D., Riggs W. |
2004 |
|
Frequency of infant adverse events that are associated with citalopram use during breast-feeding.
|
Lee A., Woo J., Ito S. |
2004 |
|
Follow-up of children of depressed mothers exposed or not exposed to antidepressant drugs during pregnancy.
|
Casper RC., Fleisher BE., Lee-Ancajas JC., Gilles A., Gaylor E., DeBattista A., Hoyme HE. |
2003 |
|
Outcomes of prenatal antidepressant exposure.
|
Simon GE., Cunningham ML., Davis RL. |
2002 |
|
Child development following exposure to tricyclic antidepressants or fluoxetine throughout fetal life: a prospective, controlled study.
|
Nulman I., Rovet J., Stewart DE., Wolpin J., Pace-Asciak P., Shuhaiber S., Koren G. |
2002 |
|
Pregnancy outcome following gestational exposure to venlafaxine: a multicenter prospective controlled study.
|
Einarson A., Fatoye B., Sarkar M., Lavigne SV., Brochu J., Chambers C., Mastroiacovo P., Addis A., Matsui D., Schuler L., Einarson TR., Koren G. |
2001 |
|
Outcome of children exposed in utero to fluoxetine: a critical review.
|
Koren G., Nulman I., Addis A. |
1998 |
|
Pregnancy outcome following first-trimester exposure to fluoxetine (Prozac)
|
Pastuszak A., Schick-Boschetto B., Zuber C., Feldkamp M., Pinelli M., Sihn S., Donnenfeld A., McCormack M., Leen-Mitchell M., Woodland C. |
1993 |
|
A controlled study of fluoxetine and cognitive-behavioural counselling in the treatment of postnatal depression.
|
Appleby L., Warner R., Whitton A., Faragher B. |
1997 |
|
Neurodevelopment of children exposed in utero to antidepressant drugs.
|
Nulman I., Rovet J., Stewart DE., Wolpin J., Gardner HA., Theis JG., Kulin N., Koren G. |
1997 |
|
Association of maternal lithium exposure and premature delivery.
|
Troyer WA., Pereira GR., Lannon RA., Belik J., Yoder MC. |
-- Not Found -- |
|
Lithium and pregnancy. A cohort study on manic-depressive women.
|
Källén B., Tandberg A. |
1983 |
|
Hydroxyzine for controlling postpartum anxiety: a double-blind study.
|
Reisner JG. |
1967 |
|
One-Year Developmental Outcomes for Infants of Mothers With Bipolar Disorder.
|
Santucci AK., Singer LT., Wisniewski SR., Luther JF., Eng HF., Sit DK., Wisner KL. |
-- Not Found -- |
|
Continuation of Atypical Antipsychotic Medication During Early Pregnancy and the Risk of Gestational Diabetes.
|
Park Y., Hernandez-Diaz S., Bateman BT., Cohen JM., Desai RJ., Patorno E., Glynn RJ., Cohen LS., Mogun H., Huybrechts KF. |
2018 |
|
Pregnancy outcomes following maternal exposure to second-generation antipsychotics given with other psychotropic drugs: a cohort study.
|
Sadowski A., Todorow M., Yazdani Brojeni P., Koren G., Nulman I. |
2013 |
|
Exposure to selective serotonin reuptake inhibitors and the risk of congenital malformations: a nationwide cohort study.
|
Jimenez-Solem E., Andersen JT., Petersen M., Broedbaek K., Jensen JK., Afzal S., Gislason GH., Torp-Pedersen C., Poulsen HE. |
2012 |
|
Birth weight and use of olanzapine in pregnancy: a prospective comparative study.
|
Babu GN., Desai G., Tippeswamy H., Chandra PS. |
2010 |
|
Risks associated with antipsychotic treatment in pregnancy: Comparative cohort studies based on electronic health records.
|
Petersen I., Sammon CJ., McCrea RL., Osborn DPJ., Evans SJ., Cowen PJ., Nazareth I. |
2016 |
|
Zolpidem (Ambien) in pregnancy: placental passage and outcome.
|
Juric S., Newport DJ., Ritchie JC., Galanti M., Stowe ZN. |
2009 |
|
Duration of antidepressant use during pregnancy and risk of major congenital malformations.
|
Ramos E., St-André M., Rey E., Oraichi D., Bérard A. |
2008 |
|
Bipolar disorder and psychotropic medication: Impact on pregnancy and neonatal outcomes.
|
Wisner KL., Sit D., O'Shea K., Bogen DL., Clark CT., Pinheiro E., Yang A., Ciolino JD. |
2019 |
Comments (
Creative Commons